Accurate glucose monitoring 24/7
with the ease of a smartband
Smart band
Wrist-worn band performing
optical measurements
Mobile application
Display glucose levels,
uploads data to the cloud
uploads data to the cloud
Cloud analytics
Data is analyzed to provide insights
Why Wizmi
Clinical-grade non-invasive CGM making treatment compliance seamless
- Wearable, needle-free monitoring
- Continuous clinical-grade data
- No disposable sensors
Wizmi recently received FDA Breakthrough Device Designation and is on track to become an FDA cleared non-invasive wearable CGM.
Diabetes is a real pain.
Non-invasive matters!
Needle-based CGM causes pain, inconvenience, and recurring sensor costs. As a result, most patients, especially those with Type 2 diabetes and prediabetes, do not monitor glucose consistently, reducing treatment effectiveness and increasing complications and health risks.
140m
Americans live with diabetes or prediabetes
9 in 10
diabetes patients are Type 2
Beyond diabetes
Wizmi is initially designed for adults (18+) with Type 2 diabetes and prediabetes, and individuals who want to monitor and optimize their metabolic health.
In the future, it will also support people with Type 1 Diabetes, as well as the 1 in 6 expectant mothers at risk of gestational diabetes (GDM).
